Form 4: Ocugen Director Uday Kompella Acquires Options in Latest Transaction
SEC Form 4
Director Uday Kompella acquired options to purchase 66,929 shares of Ocugen, Inc. common stock.
Summary
- On June 28, 2024, Uday Kompella, a director of Ocugen, Inc., acquired options to purchase 66,929 shares of the company's common stock at an exercise price of $1.55.
- The options vest on the earlier of June 28, 2025, or Ocugen's next annual meeting of stockholders, contingent upon continued service.
- Following the transaction, Kompella directly owns 66,929 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating insider activity, which can be interpreted as a sign of confidence, but it doesn't provide strong positive or negative signals.
Positives
- A director's acquisition of options can be seen as a positive sign, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- Shareholders may view the director's acquisition of options as a positive signal, potentially increasing confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 06/28/2024 | Date of the transaction: Uday Kompella acquired options to purchase Ocugen, Inc. common stock. |
| 06/28/2025 | Earliest vesting date for the options, contingent upon continued service or the next annual meeting of stockholders. |
| 06/28/2034 | Expiration date of the options. |
| 07/02/2024 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.